Authorship of the paper:
Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. The journal follows the International Committee of Medical Journal Editors Criteria which recommends that authorship be based on the following 4 criteria:

•    Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
•    Drafting the work or revising it critically for important intellectual content; AND
•    Final approval of the version to be published; AND
•    Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
The full policy is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

 

Disclosure and conflicts of interest:

All submissions must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal follows the International Committee of Medical Journal Editors policy. The full policy is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html

The International Committee of Medical Journal Editors Disclosure Form may be used which declares:

•    Authors’ relationships and activities; and
•    Sources of support for the work, including sponsor names along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; any restrictions regarding the submission of the report for publication; or a statement declaring that the supporting source had no such involvement or restrictions regarding publication; and
•    Whether the authors had access to the study data, with an explanation of the nature and extent of access, including whether access is ongoing.

Peer Review

The journal follows the International Committee of Medical Journal Editors policy. The full policy is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/responsibilities-in-the-submission-and-peer-peview-process.html

The Editor-in-Chief will ensure that appropriate reviewers are selected based on expertise and impartiality. The reviewers will have access to all materials that may be relevant to the evaluation of the manuscript. Reviewers will be asked prior to review if they have relationships or activities that could compromise their review. Reviewers must disclose to editors any relationships or activities that could bias their opinions of the manuscript and should recuse themselves from reviewing specific manuscripts if the potential for bias exists.

We perform a single-blinded review of submitted manuscripts. The authors’ identities and affiliations are known to reviewers. Making this information available to reviewers ensures that reviewers can identify any potential conflict of interest and recuse themselves if appropriate.

However, authors can opt for a double-blind review of the manuscript on request at the time of submission of the manuscript.

Peer Review

Transparent, Constructive, and Equitable Peer Review: JVIN recognizes the important contributions of its authors and reviewers and is dedicated to ensuring a constructive and fair evaluation process for research submissions. All editorial decisions are rendered by journal editors who are actively engaged as research scientists within the relevant field.

Every manuscript is treated by the Editors and reviewers as privileged information, and they are instructed to exclude themselves from the review of any manuscript that might involve a conflict of interest or the appearance thereof. The Editor-in-Chief will ensure that appropriate reviewers are selected based on expertise and impartiality. The reviewers will have access to all materials that may be relevant to the evaluation of the manuscript. Reviewers will be asked prior to review if they have relationships or activities that could compromise their review. Reviewers must disclose to editors any relationships or activities that could bias their opinions of the manuscript and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. 

We perform a single-blinded review of submitted manuscripts. The authors’ identities and affiliations are known to reviewers. Making this information available to reviewers ensures that reviewers can identify any potential conflict of interest and recuse themselves if appropriate. However, authors can opt for a double-blind review of the manuscript on request at the time of submission of the manuscript. 

At any point during the review process, authors may be asked to provide high-resolution images of their original data or other information needed to robustly assess technical quality. Authors can draw our attention to potential conflicts of interest by indicating the name of “opposed reviewers” during submission. Authors are required to explain (in detail) why they do not want the indicated person to be invited.

All information pertaining to the editorial and peer review process of submitted articles should be kept confidential by editors, authors, and reviewers. The peer review process is anonymous and confidential, and the identity of reviewers are not disclosed unless specifically stated as part of open peer review. Reviewers are required to keep manuscripts confidential. When evaluating a manuscript, a reviewer who wants to consult with colleagues must speak with the editor, make sure that confidentiality is maintained, and send the journal the names of any such peers along with the final report.  

Correspondence with the journal, referees' reports, and other private information shall not be published, divulged, or otherwise made public without prior written consent, regardless of whether a submitted work is ultimately published. Reviewers should be informed that we take every precaution to maintain the confidentiality of their names, as it is our policy to do so. However, we cannot promise to uphold this secrecy in case an identity disclosure lawsuit is successful.

To further uphold the integrity of the peer review process, the journal periodically reviews its policies and practices to adapt to emerging ethical standards and technological advancements. Training and guidance are provided to all participants in the editorial workflow to clarify expectations around impartiality, confidentiality, and responsible communication. The journal encourages ongoing dialogue between editors, reviewers, and authors to address concerns or ambiguities, fostering a professional environment that prioritizes fairness, transparency, and accountability. All parties are reminded that adherence to these principles is essential not only for the protection of individual reputations but also for maintaining the trust and credibility of the scientific community at large.

Ethical Policies

An important consideration in the review, editorial, and publication processes of papers is the integrity of the journal material that is published. Therefore, authors, reviewers, and editorial board members of JVIN are expected to abide strictly by our publication ethics and malpractice standards. 

Authors

Content and Authorship: JVIN-papers must be original and meet strict technical (language, artwork, etc.) and scientific (content) requirements. As a general policy, JVIN does not publish manuscripts describing essentially the same research as published in another journal. The authors should include original works, and the work and/or words of others appropriately cited or quoted. Authors should be prepared to provide public access to the raw data in connection with a paper for editorial review. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. To ensure that papers are original contributions, and to avoid copyright issues, authors must adhere to these. All co-authors must be aware of the contents of the submission. All co-authors agree with the copyright policy and the Open Access policy of the journal. The corresponding author declares that the manuscript and the illustrations within are original, or that he/she has taken all the necessary steps to avoid breach of copyright.

Originality and Plagiarism: The authors should make sure that their work is original and that any quotes or statements they have included from other people have been properly cited.  When applicable, authors who have written papers on the subject are expected to cite such works; nevertheless, they should refrain from over- or inappropriately citing themselves. For an ethical publication, the following are regarded as fundamentals: Content integrity; sound methodology, presentation, and sources; reproducibility of results; acknowledgment of research and data collection contributors; and acknowledgment of funding agencies and/or prior institutions where (part of) the work was conducted.

Plagiarism should be avoided and it is unacceptable. Strict COPE rules have been adopted by JVIN to detect plagiarism; situations involving substantial plagiarism will be addressed in accordance with the criteria, and the editor has every right to notify the author's institution of the incident. As a CrossCheck member, United Scientific Group (USG) verifies the originality of submitted publications using the iThenticate plagiarism detection system.

To prevent self-plagiarism, authors should clearly identify previously published material by providing comprehensive citations, using quotation marks for direct excerpts, and paraphrasing to introduce original context or insights. Adhering to these ethical standards promotes transparency, enabling readers to distinguish between new contributions and existing scholarship.

Scientific misconduct: Fabricating or maliciously altering data, including images, is prohibited. Authors must keep accurate records of reliable data. Any deliberate manipulation or omission of information to achieve a desired outcome is considered fraud.

Reproducibility of Results:  Authors are required to include a data availability statement (DAS) in their manuscript when sharing research datasets. This statement should provide direct links to the relevant data, which may be presented as supplementary files or hosted in external data repositories. Datasets must be accessible to readers upon publication and available to referees during the review process. Additionally, authors are encouraged to utilise institutional websites, personal webpages, or established research repositories to support effective data reuse.

Disclosure and Conflicts of Interest: All submissions must include disclosure of any relationships that may be considered potential conflicts of interest.

Reviewers

During the peer-review process, reviewers are expected to maintain the highest ethical standards and treat all unpublished manuscript content as strictly confidential. Reviewers must promptly disclose any potential conflicts of interest—whether financial or personal—to the editor. All co-authors are required to agree to the journal's Open Access and copyright policies. Reviewers should provide authors with clear, concise, and objective feedback, avoiding personal criticism or comments regarding acceptance or rejection. Constructive remarks should be offered to help authors improve the quality of their manuscript.

Editors

When the review process concludes, the Managing editor or editor-in-chief determines whether to accept or reject the submission, relying on the recommendations and reports provided by the reviewers. In the event of a conflict of interest between an author and an editor, the editor involved will abstain from participating in both the review and decision-making processes. Researchers must present their original findings with a precise description of the work conducted, along with an unbiased assessment of its importance. 

Human or animal subjects: Statements of compliance are necessary if the work uses chemicals, equipment, or methods that have unusual hazards associated with their usage, or if it involves human or animal subjects.

Informed consent for patient images or case details: Research involving patients or volunteers must obtain approval from an ethics committee and secure informed consent, both of which should be clearly documented in the report.

Privacy Statement: Names, affiliations, and contact email addresses provided through the journal platform will be used solely for the purposes specified by this journal and will not be disclosed for any other reason or to any third parties.

 

Originality, accuracy, scientific conduct, and plagiarism:

The journal does not publish manuscripts as a general policy describing essentially the same research as published in another journal. The authors should write the original works, and the work and/or words of others appropriately cited or quoted. Authors should be prepared to provide public access to the raw data in connection with a paper for editorial review.

 

Protection of research subjects, research animals, and informed consent:

The journal follows the International Committee of Medical Journal recommendations for the protection of human subjects. The policies are available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html. All investigators should ensure that the planning conduct and reporting of human research are in accordance with the Helsinki Declaration (2013 revision). All authors should seek approval to conduct research from an independent local, regional, or national review body (e.g., ethics committee, institutional review board). The editors may form their own judgment as to whether the conduct of the research was appropriate. Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Patient consent should be written and archived with the authors, as dictated by local regulations or laws. Our journal does not archive the consent to avoid being aware of patient identity and patient confidentiality is better guarded by having the author archive the consent. When informed consent has been obtained, it should be indicated in the published article. When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals were followed. Further guidance on animal research ethics is available at http://www.veteditors.org/consensus-author-guidelines-on-animal-ethics-and-welfare-for-editors.

 

Registration of Clinical Trials:

The journal follows the International Committee of Medical Journal recommendations (see http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html). Our journal requires registration of clinical trials in a public trials registry at or before the time of first patient enrollment as a condition of consideration for publication. We accept publicly accessible registration in any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) that includes the minimum acceptable 24-item trial registration dataset or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP.

 

Data sharing:

The journal follows the International Committee of Medical Journal recommendations. The data sharing statement policy is provided as follows: http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html The Journal of Vascular and Interventional Neurology requires that report the results of clinical trials must contain a data sharing statement. Data sharing statements must indicate the following: whether individual de-identified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer); what data in particular will be shared; whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.); when the data will become available and for how long; by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).

 

Other policies:

The journal follows the International Committee of Medical Journal recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. The policies are available at http://www.icmje.org/icmje-recommendations.pdf

 

Fees or charges:

The journal is one of very few public access journals that do not charge any fees or charges for manuscript processing and/or publishing materials in the journal for review. The journal and individual articles are available to readers without charges. The journal is supported by an endowment from Zeenat Qureshi Stroke Institutes.

Advertising

The journal permits the advertisement of products with direct relevance to cerebrovascular diseases. The Editorial Board will decide the appropriateness of the content. Charges will apply to any advertisement.